Pharmaceutical

FDA approves GSK’s Blujepa for uncomplicated UTIs

The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infections (uUTIs) in adult females and paediatric patients.

Mar 27, 2025 - 06:00
FDA approves GSK’s Blujepa for uncomplicated UTIs
The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infections (uUTIs) in adult females and paediatric patients.
Read the original article

Tags:

Previous Article

Unmatched quality in pharmaceutical logistics: Why it matters

Next Article

Big pharma faces headwinds in China as vaccine sales decline

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: From a small town in Wales, a scientific sleuth has shaken Dana-Farber — and elevated the issue of research integrity

STAT+: From a small town in Wales, a scientific sleuth ...

Jan 28, 2024

STAT+: Insurance alone didn’t guarantee adherence to Ozempic, study finds

STAT+: Insurance alone didn’t guarantee adherence to Oz...

Jun 4, 2023

Investors optimistic about continued biotech and medtech IPO resurgence in 2025

Investors optimistic about continued biotech and medtec...

Dec 25, 2024